PET/MR in oncology: an introduction with focus on MR and future perspectives for hybrid imaging.
about
Biomedical applications of functionalized hollow mesoporous silica nanoparticles: focusing on molecular imagingNanobody: the "magic bullet" for molecular imaging?Integrated whole body MR/PET: where are we?A Clinical and Experimental Comparison of Time of Flight PET/MRI and PET/CT SystemsHaloTag as a reporter gene: positron emission tomography imaging with (64)Cu-labeled second generation HaloTag ligandsMolecular imaging strategies for in vivo tracking of microRNAs: a comprehensive review.Quantum dot-based nanoprobes for in vivo targeted imaging.Chelator-free synthesis of a dual-modality PET/MRI agent.PET/MRI of Hypoxic Atherosclerosis Using 64Cu-ATSM in a Rabbit Model.Synthesis and biomedical applications of copper sulfide nanoparticles: from sensors to theranostics.Multimodality imaging of RNA interferencePositron emission tomography in the follow-up of cutaneous malignant melanoma patients: a systematic reviewPET/MR imaging of atherosclerosis: initial experience and outlook.Image quality assessment of automatic three-segment MR attenuation correction vs. CT attenuation correction.How PET/MR Can Add Value For Children With Cancer.Speeding up PET/MR for cancer staging of children and young adults.Integrated whole-body PET/MRI with 18F-FDG, 18F-FDOPA, and 18F-FDA in paragangliomas in comparison with PET/CT: NIH first clinical experience with a single-injection, dual-modality imaging protocol.Upcoming imaging concepts and their impact on treatment planning and treatment response in radiation oncology
P2860
Q26827998-39FCEBFE-1DD1-407F-A84D-CBCF55724378Q30442626-335B8CBC-B2F4-40F2-A7EF-55A9BE4EED3BQ34975185-9208667B-E30D-431C-8642-D774F2964481Q36621641-55DB450A-D56E-49C3-9554-7E93CE2801CEQ36788992-C003A807-0C8F-4347-9B22-41CBD1F3DB3BQ37110373-285E844E-8762-4283-8085-2E5F5706C93FQ37337213-D378FBC8-4BE3-4006-B7F7-0A9FE2875CC6Q37374640-450556F3-C8B2-46A5-B50B-A9266345C6EDQ37449411-9D271340-7329-41FE-8299-A5D4ABAE2188Q37649861-DD257543-2B45-4D68-9DEA-BE77F86BB735Q38112726-7CCAE1AF-14D3-4FCA-BA2E-A93AEE291C17Q38174901-F6992178-22B1-4979-81E3-39079EE5BF7DQ39334798-E7720EBA-6CBF-498A-8D7A-3139BE19B86CQ39426177-7E55D659-EA32-4DE4-8598-217A15B1D192Q39427334-F902F86D-05CE-4CDC-A736-629B5A8897DFQ39860692-41989A91-360E-4928-AD62-8E0F88179D96Q41207387-5A597DFD-56D0-4AF6-BA69-175E285C9BBBQ58787312-C0F266CF-B93A-4B7E-86CF-1E11BCF3BC1A
P2860
PET/MR in oncology: an introduction with focus on MR and future perspectives for hybrid imaging.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
PET/MR in oncology: an introdu ...... rspectives for hybrid imaging.
@ast
PET/MR in oncology: an introdu ...... rspectives for hybrid imaging.
@en
type
label
PET/MR in oncology: an introdu ...... rspectives for hybrid imaging.
@ast
PET/MR in oncology: an introdu ...... rspectives for hybrid imaging.
@en
prefLabel
PET/MR in oncology: an introdu ...... rspectives for hybrid imaging.
@ast
PET/MR in oncology: an introdu ...... rspectives for hybrid imaging.
@en
P2093
P2860
P1476
PET/MR in oncology: an introdu ...... rspectives for hybrid imaging.
@en
P2093
Barbara M Fischer
Johan Löfgren
Svetlana Balyasnikova
Yanna Zamogilnaya
P2860
P304
P577
2012-10-15T00:00:00Z